Shibata S, Asano T, Ogura A, Hashimoto N, Hayakawa J, Uetsuka K, Nakayama H, Doi K
Department of Veterinary Science, National Institute of Health, Tokyo, Japan.
Lab Anim. 1997 Apr;31(2):163-8. doi: 10.1258/002367797780600107.
SCID-bg (scid/scid, beige/beige) is a strain of double-mutant mice with impaired lymphoid development and reduced natural killer (NK) cell activity. The present study was undertaken to evaluate the usefulness of SCID-bg mice as xenograft recipients. Fetal guinea pig tissues (liver, thymus, spleen) were transplanted under the kidney capsule of the mice and their serum guinea pig IgG levels were measured weekly thereafter, C.B.-17-scid and anti-asialo GM1 antiserum-treated (NK-depleted) C.B.-17-scid (C.B.-17-scid-AGM1) mice that received the identical transplants were used as controls. Throughout the experimental period (1, 2, and 3 weeks after transplantation), the average serum guinea pig IgG concentrations was highest in C.B.-17-scid-AGM1 mice followed by SCID-bg mice and lowest in C.B.-17-scid mice without antiserum treatment, though we could not find any statistical significance among these groups. However, SCID-bg mice always showed the smallest within-group variance (individual difference) in the serum guinea pig IgG concentrations (P < 0.05, versus C.B.-17-scid-AGM1 mice at 1, 2, and 3 weeks and versus C.B.-17-scid mice at 2 weeks). The graft size was not significantly different among these three groups, but the spleen grafts in C.B.-17-scid mice contained fewer nucleate cells than the other two groups. These results indicate that the reduced NK cell activity by beige mutation is not crucial for the success of xenogenic transplantation, though SCID-bg mice may be useful as xenograft recipients with a consistent potential to retain the viability and function of engrafted tissues.
SCID-bg(scid/scid,beige/beige)是一种双突变小鼠品系,其淋巴发育受损,自然杀伤(NK)细胞活性降低。本研究旨在评估SCID-bg小鼠作为异种移植受体的实用性。将豚鼠胎儿组织(肝脏、胸腺、脾脏)移植到小鼠肾包膜下,此后每周测量其血清豚鼠IgG水平,将接受相同移植的C.B.-17-scid和抗唾液酸GM1抗血清处理(NK细胞耗竭)的C.B.-17-scid(C.B.-17-scid-AGM1)小鼠作为对照。在整个实验期(移植后1、2和3周),C.B.-17-scid-AGM1小鼠的平均血清豚鼠IgG浓度最高,其次是SCID-bg小鼠,未接受抗血清处理的C.B.-17-scid小鼠最低,尽管我们在这些组之间未发现任何统计学意义。然而,SCID-bg小鼠血清豚鼠IgG浓度的组内方差(个体差异)始终最小(与1、2和3周时的C.B.-17-scid-AGM1小鼠相比,以及与2周时的C.B.-17-scid小鼠相比,P<0.05)。这三组之间的移植物大小无显著差异,但C.B.-17-scid小鼠的脾脏移植物中的有核细胞比其他两组少。这些结果表明,米色突变导致的NK细胞活性降低对于异种移植的成功并非至关重要,尽管SCID-bg小鼠可能作为异种移植受体有用,具有一致的潜力来维持植入组织的活力和功能。